|
1
|
Nelson P, Dugbartey GJ, McFarlane L, McLeod P, Major S, Jiang J, O'Neil C, Haig A, Sener A. Effect of Sodium Thiosulfate Pre-Treatment on Renal Ischemia-Reperfusion Injury in Kidney Transplantation. Int J Mol Sci 2024; 25:9529. [PMID: 39273476 PMCID: PMC11395123 DOI: 10.3390/ijms25179529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Revised: 08/30/2024] [Accepted: 08/31/2024] [Indexed: 09/15/2024] Open
Abstract
We recently reported in a rat model of kidney transplantation that the addition of sodium thiosulfate (STS) to organ preservation solution improved renal graft quality and prolonged recipient survival. The present study investigates whether STS pre-treatment would produce a similar effect. In vitro, rat kidney epithelial cells were treated with 150 μM STS before and/or during exposure to hypoxia followed by reoxygenation. In vivo, donor rats were treated with PBS or 2.4 mg/kg STS 30 min before donor kidneys were procured and stored in UW or UW+150 μM STS solution at 4 °C for 24 h. Renal grafts were then transplanted into bilaterally nephrectomised recipient rats which were then sacrificed on post-operative day 3. STS pre-treatment significantly reduced cell death compared to untreated and other treated cells in vitro (p < 0.05), which corresponded with our in vivo result (p < 0.05). However, no significant differences were observed in other parameters of tissue injury. Our results suggest that STS pre-treatment may improve renal graft function after transplantation.
Collapse
Affiliation(s)
- Pierce Nelson
- Department of Microbiology & Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
| | - George J Dugbartey
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
- Multi-Organ Transplant Program, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
- London Health Sciences Center, Department of Surgery, Western University, London, ON N6A 5A5, Canada
- Department of Pharmacology & Toxicology, School of Pharmacy, College of Health Sciences, University of Ghana, Accra P.O. Box LG43, Ghana
| | - Liam McFarlane
- Department of Microbiology & Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
| | - Patrick McLeod
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
| | - Sally Major
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
| | - Jifu Jiang
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
| | - Caroline O'Neil
- The Molecular Pathology Core, Robarts Research Institute, London, ON N6A 5A5, Canada
| | - Aaron Haig
- Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 5A5, Canada
| | - Alp Sener
- Department of Microbiology & Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada
- Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
- Multi-Organ Transplant Program, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada
- London Health Sciences Center, Department of Surgery, Western University, London, ON N6A 5A5, Canada
| |
Collapse
|
|
2
|
Eccher A, Becker JU, Pagni F, Cazzaniga G, Rossi M, Gambaro G, L’Imperio V, Marletta S. The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective. Life (Basel) 2024; 14:254. [PMID: 38398762 PMCID: PMC10890315 DOI: 10.3390/life14020254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 02/11/2024] [Accepted: 02/13/2024] [Indexed: 02/25/2024] Open
Abstract
Kidney transplantation is the best treatment for end-stage renal disease since it offers the greatest survival benefit compared to dialysis. The gap between the number of renal transplants performed and the number of patients awaiting renal transplants leads to a steadily increasing pressure on the scientific community. Kidney preimplantation biopsy is used as a component of the evaluation of organ quality before acceptance for transplantation. However, the reliability and predictive value of biopsy data are controversial. Most of the previously proposed predictive models were not associated with graft survival, but what has to be reaffirmed is that histologic examination of kidney tissue can provide an objective window on the state of the organ that cannot be deduced from clinical records and renal functional studies. The balance of evidence indicates that reliable decisions about donor suitability must be made based on the overall picture. This work discusses recent trends that can reduce diagnostic timing and variability among players in the decision-making process that lead to kidney transplants, from the pathologist's perspective.
Collapse
Affiliation(s)
- Albino Eccher
- Department of Medical and Sciences for Children and Adults, University of Modena and Reggio Emilia, University Hospital of Modena, 41100 Modena, Italy
| | - Jan Ulrich Becker
- Institute of Pathology, University Hospital of Cologne, 50923 Cologne, Germany;
| | - Fabio Pagni
- Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, 20126 Milano, Italy; (F.P.); (G.C.); (V.L.)
| | - Giorgio Cazzaniga
- Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, 20126 Milano, Italy; (F.P.); (G.C.); (V.L.)
| | - Mattia Rossi
- Division of Nephrology, Department of Medicine, University of Verona, 37129 Verona, Italy; (M.R.); (G.G.)
| | - Giovanni Gambaro
- Division of Nephrology, Department of Medicine, University of Verona, 37129 Verona, Italy; (M.R.); (G.G.)
| | - Vincenzo L’Imperio
- Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, 20126 Milano, Italy; (F.P.); (G.C.); (V.L.)
| | - Stefano Marletta
- Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37129 Verona, Italy;
- Division of Pathology, Humanitas Istituto Clinico Catanese, 95045 Catania, Italy
| |
Collapse
|